Moreover, the PTEN tumour suppressor and the pro-apoptotic BIM proteins (also known as BCL2-like 11) were identified as relevant targets for miR-19 activity in B-cell lymphoma [16]. This evidence concerns the gene BCL2L11 and B-cell non-Hodgkin lymphoma.